Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study.
- Resource Type
- Article
- Source
- BMJ Open; Aug2020, Vol. 10 Issue 8, p1-10, 10p
- Subject
- Language
- ISSN
- 20446055